Tuesday, Sept. 15, 2026: 5 things you need to know

Abbott Laboratories will pay $385 million to resolve allegations of submitting false claims to federal and state programs. The U.S. Attorney's office claimed Abbott failed to meet safety standards for infant formula and nutritional therapy products between 2018 and 2022. The settlement includes $348.7 million to the U.S. and $36.3 million to certain states.

Abbott Laboratories agreed to a $385M settlement with the U.S. DOJ over unsanitary conditions at its Sturgis baby formula factory, which led to a 2022 recall and national shortage. The settlement resolves claims of selling contaminated formula through government programs. Three whistleblowers will receive $69M. Abbott denies liability and faults.

Abbott Laboratories will pay $385 million to settle a case regarding contamination at its Sturgis, MI baby formula plant. The plant, the largest in the U.S., was closed in 2022 due to safety concerns, causing formula shortages. The settlement follows criticism from former FDA director Dr. Robert Califf.

Abbott Laboratories will pay $384 million to settle claims it sold contaminated infant formula through federal and state programs. The DOJ accused Abbott of manufacturing products in unsanitary conditions, which the company denies. The settlement includes payments to the U.S. government, states, and whistleblowers. Abbott recalled its Similac, Alimentum, and EleCare formulas in 2022.

Abbott Laboratories agreed to pay $385m to settle US government claims related to its 2022 infant formula recall. The settlement resolves DOJ and state legal cases, with Abbott denying fault. The recall caused a US formula shortage. Abbott will pay $348.7m to the federal government and $36.3m to states. The DOJ accused Abbott of non-compliance and unsafe production practices. Abbott maintains its products were safe, citing negative tests for Cronobacter sakazakii.

Oregon will receive $977,558 from a multi-state settlement with Abbott Laboratories over allegations of unsafe baby formula production. The settlement, totaling over $384 million, involves claims that Abbott failed to maintain safe conditions at its Michigan and Arizona facilities from 2018 to 2022.